Article Details

Early biopharma investment nears $5B and IPOs are up, but newly public companies face sluggish ...

Retrieved on: 2021-07-23 14:57:04

Tags for this article:

Click the tags to see associated articles and topics

Early biopharma investment nears $5B and IPOs are up, but newly public companies face sluggish .... View article details on HISWAI: https://www.fiercebiotech.com/biotech/biopharma-series-a-and-ipos-skyrocket-but-post-ipo-and-m-a-performance-down-1h21-report

Excerpt

... doubled year-over-year to $4.69 billion across the U.S. and Europe for the critical series A round, according to a new report by Silicon Valley Bank.

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up